$10 Million Funding For Technologie Biolactis, Inc., A Canadian Biotechnology Company

SAGUENAY, QC, Feb. 7 /CNW/ - Technologie Biolactis, Inc., a Canadian biotechnology company specializing in the development of lactoceuticals focused on cardiovascular, metabolism and obesity-associated disorders, announced the completion of its Series A financing round of $7.3 million CAD with provision for follow on capital ($1.4 million). The round was led by Inventages Venture Capital Investments Inc. Biolactis also improves its balance sheet by conversion onto equity of the long-term liabilities held by Investissement Québec, Amisk and CQVB totalling $1.9 million.

Back to news